Gene · 58191
Papers4,127
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,127
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association between inflammatory bowel disease and interleukins, chemokines: a two-sample bidirectional mendelian randomization study. | Front Immunol | 2023 | 37228614 | PubTator, text mining | PubMed |
| Single-cell landscape dissecting the transcription and heterogeneity of innate lymphoid cells in ischemic heart. | Front Immunol | 2023 | 37228603 | PubTator, text mining | PubMed |
| The Role of CCL3 in the Pathogenesis of Rheumatoid Arthritis. | Rheumatol Ther | 2023 | 37227653 | PubTator, text mining | PubMed |
Abnormal activation of NF-κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid-derived suppressor cells to shape the immunosuppressive tumor immune microenvironment. | Thorac Cancer | 2023 | 37221702 | PubTator, text mining | PubMed |
| Neuropilin-1 interacts with VE-cadherin and TGFBR2 to stabilize adherens junctions and prevent activation of endothelium under flow. | Sci Signal | 2023 | 37220183 | PubTator, text mining | PubMed |
| New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer. | Mol Ther Oncolytics | 2023 | 37215386 | PubTator, text mining | PubMed |
| Cuproptosis-a potential target for the treatment of osteoporosis. | Front Endocrinol (Lausanne) | 2023 | 37214253 | PubTator, text mining | PubMed |
| Analysis of immunogenic cell death in ascending thoracic aortic aneurysms based on single-cell sequencing data. | Front Immunol | 2023 | 37207221 | PubTator, text mining | PubMed |
| Innate immunity and early liver inflammation. | Front Immunol | 2023 | 37205101 | PubTator, text mining | PubMed |
| Systematic pan-cancer analysis identifies cuproptosis-related gene DLAT as an immunological and prognostic biomarker. | Aging (Albany NY) | 2023 | 37199628 | PubTator, text mining | PubMed |
| New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine. | Cell Mol Immunol | 2023 | 37198402 | PubTator, text mining | PubMed |
| ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma. | BMC Cancer | 2023 | 37193981 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or Resistance. | Biomedicines | 2023 | 37189643 | PubTator, text mining | PubMed |
| sCXCL16 as a prognostic biomarker for COVID-19 outcome. | J Med Virol | 2023 | 37185869 | PubTator, text mining | PubMed |
| Low-grade glioma risk SNP rs11706832 is associated with type I interferon response pathway genes in cell lines. | Sci Rep | 2023 | 37185361 | PubTator, text mining | PubMed |
| Changes in the mammary gland during aging and its links with breast diseases. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37184281 | PubTator, text mining | PubMed |
| Future directions in acute liver failure. | Hepatology | 2023 | 37183883 | PubTator, text mining | PubMed |
| Molecular and biologic biomarkers of Ewing sarcoma: A systematic review. | J Bone Oncol | 2023 | 37180735 | PubTator, text mining | PubMed |
| Serum cytokine and chemokine profiles and disease prognosis in hepatitis B virus-related acute-on-chronic liver failure. | Front Immunol | 2023 | 37180134 | PubTator, text mining | PubMed |
| Differential Response of Mycosis Fungoides Cells to Vorinostat. | Int J Mol Sci | 2023 | 37175780 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58191/papers?page=30